Venlor XR capsules.

Venlor XR capsules.

S5
PDF Leaflet Revision Date: 07 November 2024

API: Venlafaxine | Company: Cipla Medpro

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of depression and anxiety disorders.

Dosage (summary)

75 mg once daily, may increase to 150 mg or 225 mg as needed.

Special Populations

  • Renal impairment
  • Hepatic impairment
  • Elderly patients

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation.

Key Drug Interactions

  • MAOIs
  • Warfarin
  • CYP2D6 inhibitors
  • CYP3A4 inhibitors

Contraindications

  • Hypersensitivity to venlafaxine
  • Children under 18 years
  • Pregnancy
  • Lactation

Common side effects

  • Nausea
  • Dizziness
  • Dry mouth
  • Insomnia
  • Headache

Counselling Points

  • Take with food
  • Do not discontinue abruptly
  • Monitor for mood changes
  • Avoid alcohol

Serious warnings

  • Risk of suicidal thoughts
  • Serotonin syndrome
  • Increased blood pressure
  • Convulsions
Important Disclaimer

The Venlor XR capsules. professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites